How should we advertise products with policy limits on Google, such as supplements?
Our answer
Check every product, ingredient and claim against Google's healthcare rules before spending, and run only what qualifies. Keep ads, pages and feeds free of disease and fast weight loss claims. Drop remarketing lists if Google classes the product as Health.
- Confidence
- High
- Strongest proof
- 10 Google rules
- 5 practitioners, 1 opinion or claim
- Sources
- 7 sources
- 16 statements
- G
AHFOCC
New here? Take the 1-minute tour
Why this is the answer
3 reasons and our judgmentGoogle bars products by ingredient and claim. Its unapproved list covers ephedra, hCG for weight loss and supplements with active drug ingredients. Compliant supplements need no certification (AdBoost Health, a health brand marketing agency).
A clean ad still fails when the formula or product page breaks the rules. Google judges the landing page as well as the ad (AdBoost Health, Fueld).
Health products can't use your own audience lists. Google bars customer lists, remarketing and lookalikes for Health products and says Demand Gen uses those audiences by default. OuterBox, Curve Compliance and PPC Land flag the Demand Gen risk for health advertisers.
Our judgment
- Clear each product and market before spending. Check every ingredient against Google's unapproved list and read the product page the way Google will. Fueld says no ad rewrite approves a prohibited product, and Eva keeps a policy record for each product and market.
- Write to support for normal health, not treatment of a condition, across ads, pages, feeds and testimonials. Fueld says testimonials aren't a loophole and weight products draw unreliable claims rejections. AdBoost Health keeps pages to structure and function claims, and Eva avoids miracle language.
- If Google classes the product as Health, build on keywords and Google's predefined audiences. Strip customer lists, remarketing, lookalikes and audience expansion from every level, Demand Gen included, as Google, OuterBox, Curve Compliance and PPC Land describe.
- Answer a disapproval by fixing its cause and appealing with evidence. Fix the product, page or targeting. Never resubmit the same claim reworded or move ads into another account. Eva warns against repeated resubmission, and Curve Compliance points to Google's rule against new accounts and ad variations.
Our judgment, built from AdBoost Health, Fueld, Eva, Google, OuterBox, Curve Compliance and PPC Land: our reading of these sources, not a finding from any one of them.
What the sources say
16 statements from 7 sourcesGoogle bans ads for certain supplements, such as those with ephedra or drug-like claims, warns at least 7 days before suspending an account, and allows CBD ads only with certification in a few places.
“Google will issue a warning at least 7 days before suspending your account.”
Google lets certified drug makers advertise prescription and over-the-counter medicines only in select locations, and suspends advertisers offering prescription drugs without a prescription without warning.
“This suspension occurs upon detection and without prior warning. You will not be allowed to advertise with Google Ads again.”
Google Merchant Center bans unapproved pharmaceuticals and supplements, including chemically similar substances, with a warning at least 7 days before suspension; unauthorized pharmacies are suspended without warning.
“A warning will be issued at least 7 days prior to any suspension of your account.”
Google bans ads with unproven cures or unrealistic weight loss claims, requires a refund policy for guaranteed results and a disclaimer on results testimonials, and warns 7 days before suspension.
“Google will issue a warning at least 7 days before suspending your account.”
Google treats health conditions and treatments as a sensitive category: such ads can use Google's predefined audiences but not Customer Match, your data segments, audience expansion or lookalikes.
“You can't use advertiser-curated audiences.”
Google restricts personalized ad targeting for sensitive categories such as alcohol, gambling and health, and says Demand Gen campaigns aimed at them may be blocked from serving.
“Discovery and Demand Gen campaigns use advertiser-curated audiences by default and may be restricted from serving if targeting products and services that fall within sensitive interest categories.”
Google treats evading ad enforcement as egregious, including re-running variations of disapproved ads or spreading violating ads across several accounts, and suspends accounts on detection without warning.
“Spreading ads that violate Google Ads' policies across 2 or more accounts”
Google is adding NABP accreditation as a new certification option for telemedicine advertisers in the US, UK and Canada in November 2026.
“a new certification option for telemedicine”
Google says circumventing its systems, such as opening new accounts after a suspension or giving false verification details, brings suspension without warning, and advises not opening many accounts quickly.
“This suspension occurs upon detection and without prior warning.”
Curve Compliance, which sells health ad tracking, says Google bars health advertisers from customer lists, remarketing and lookalikes; keywords and Google's own audiences still work.
“Hashing a patient list before upload changes nothing either”
Google says that from October 30, 2026, alcohol ads on YouTube can use personalized targeting where alcohol is legal, except in Egypt, India, Indonesia and Poland; alcohol health targeting stays banned.
“Starting on October 30, 2026, we’re updating our personalized advertising policy for YouTube inventory to allow for alcohol where locally permitted.”
OuterBox, which sells Google Ads management, says health conditions are a sensitive category that blocks Customer Match, lookalikes and similar audiences, and mismatched product data can suppress a whole account.
“Non-egregious violations still draw a seven-day warning before suspension; egregious violations can mean immediate suspension with no warning at all”
Fueld, a paid media agency for wellness brands, says supplements with banned or warned ingredients won't be approved however ads are rewritten, and medicine-like claims on landing pages also cause disapprovals.
“If your product is prohibited, no amount of ad rewrites will lead to approval.”
Eva, which sells ad management, says supplement advertisers should keep a policy profile per SKU and market, review landing pages too, and appeal with evidence rather than resubmit reworded ads.
“Do not repeatedly resubmit the same message with superficial wording changes. Repeated issues can affect account trust.”
PPC Land says Google confirmed Demand Gen campaigns in 21 sensitive categories may simply not serve unless they rely only on Google's predefined audiences. It is not a policy warning.
“It describes it as a serving implication - the campaign may simply not deliver.”
AdBoost Health, which sells health ad services, says compliant supplements need no Google certification, but banned ingredients or drug-like claims on the landing page can get ads disapproved even with clean copy.
“The line is ingredient- and claim-based, not credential-based.”
In the full answer
For readers who sign in- What to do this week3 steps
- The numbers behind it3 figures from cited sources
- The strongest disagreementThe best case against the answer, from a cited source
- How sure we areWhat its confidence rests on, and what would change the answer